维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

12篇 您的检索式：作者名="Bell MP"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Quinolinic acid in the cerebrospinal fluid of children after traumatic injury显示文摘	Bell MJ Kochanek PM Heyes MP	1999	Crit Care Med1999，27，3：	1
	2	Cholinesterase inhibition and toxicokinetics in immature and adult rats after acute or repeated exposures to chlorpyrifos or chlorpyrifos-oxon显示文摘	Marty MS Andrus AK Bell MP	2012	RegulToxicolPharm2012，63，2：	1
	3	Problematic uterine smooth muscle neoplasms:aclinicopathologic studay of 213 cases显示文摘	Bell S Kempson RL hendrickson MP	1994	AMJ surg pathol1994，18，：	1
	4	Expression of proliferating cell nuclear antigen in gastrointestinal tract lesions and its relationship to bcl-2 expression显示文摘	Bell K Bronner MP Pasha T		0，，：	1
	5	Regulatory effects of transforming growth factor-beta on IL-2-and IL-4-dependent T cell-cycle progression显示文摘	Ruegemer JJ Ho SN Augustine JA Schlager JW Bell MP McKean DJ	1990	J Immunol1990，144，：	1
	6	Progression ofunilateral moyamoya disease: A clinical series显示文摘	KellyME Bell -Stephens TE Marks MP	2006	Cerebrovasc Dis2006，22，23：	1
	7	Hybridization,transgressive segregation,genetic covariation,and adaptive radiation显示文摘	Bell MA Travis MP		0，，：	1
	8	Cholinesteraseinhibition and toxicokinetics in immature and adult rats afteracute or repeated exposures to chlorpyrifos or chlorpyrifos - oxon显示文摘	Marty MS Andrus AK Bell MP	2012	Regul Toxicol Pharmacol2012，63，2：	1
	9	Cholinesterase inhibition and toxicokinetics in immature and adult rats after acute or repeated exposures to chlorpyrifos or chlorpyrifos- oxon显示文摘	Marty MS Andrus AK Bell MP	2012	RegulToxicolPharmacol2012，63，2：	1
	10	Influence of intron length on alternative splicing of CD44显示文摘	Bell MV Cowper AE Lefranc MP		0，，：	1
	11	Inhibition of interleukin-1-stimulated NF-kappaB Re-lA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity 显示文摘	Egan LJ Mays DC Huntoon C J Bell MP Pike MG Sandborn WJ	1999	J Biol Chem1999，274，26：	1
	12	A CFTR corrector (luma- cattor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial 显示文摘	Boyle MP Bell SC Konstan MW	2014	The Lancet Respiratory Medicine2014，2，7：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费